Molecular Diagnostics Market by Application (Infectious Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Hybridization, DNA Sequencing), End User (Hospitals, Laboratory), Product & Service (Reagent, Software) - Forecast to 2021

Publisher Name :
Date: 02-Feb-2017
No. of pages: 241
Inquire Before Buying

The global molecular diagnostics market is projected to reach USD 10.12 billion by 2021 from USD 6.54 billion in 2016, at a CAGR of 9.1% from 2016 to 2021. High prevalence of infectious diseases and various types of cancer, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market and advancements in molecular techniques; and reforms in the reimbursement system in the U.S. are the major factors driving the growth of the molecular diagnostics market. Advances in genomics and proteomics, increasing adoption of point-of-care testing, developing markets in Asia-Pacific such as China, India, Brazil, Mexico, and South Africa offer lucrative opportunities for players in the market.

The market is broadly segmented on the basis of technology, applications, products & services, end user, and region. The major technologies studied in the report include PCR, INAAT, microarrays, hybridization, DNA sequencing, and Next-generation sequencing (NGS), and other technologies (electrophoresis, flow cytometry, and mass spectrometry). Among these technologies, PCR is expected to command the largest share and microarray segment is expected to be the highest growth segment.

By products & services, the market is segmented into instruments, reagents& kits, and services & software. The reagents &kits market is expected to account for the largest share and highest CAGR of the market in 2016.
The molecular diagnostics market, by application, is classified into infectious diseases, oncology, genetics, blood screening, microbiology, and other applications (cardiovascular diseases, neurological diseases, DNA fingerprinting, tissue typing, and food pathogen detection testing). The infectious diseases segment will account for the largest share of the global market in 2016, followed by the blood screening and oncology segments.

Based on end users, the market is subsegmented into hospital & academic laboratories, reference laboratories, and other end users (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care settings, and self-testing). As most diagnostic tests are performed in-house, the hospital & academic laboratories segment is expected to dominate the market. On the other hand, newly launched, complex, and highly specialized tests are mostly offered only at a few large reference laboratories. Hence, the segment will grow at the fastest pace during the forecast period.

On the basis of region, North America is expected to account for the largest share of the global molecular diagnostics market in 2016, followed by Europe. The growth of the North American molecular diagnostics market is majorly driven by the factors such as the availability of government funds, growing applications of MDx in genetic disorders and cancer screening, and ease of use of self-monitoring techniques.

Innovative product launch was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.

Research Coverage:

This research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the molecular diagnostics market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The abovementioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output to remain successful.

Reasons to buy this report:

This research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the molecular diagnostics market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:


  • Market Penetration: Comprehensive information on products offered by the top players in the molecular diagnostics market

  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the molecular diagnostics market

  • Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for molecular diagnostics products across various regions

  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the molecular diagnostics market

  • Competitive Assessment: In-depth assessment of market ranking, strategies, products, and manufacturing capabilities of the leading players in the molecular diagnostics market

Molecular Diagnostics Market by Application (Infectious Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Hybridization, DNA Sequencing), End User (Hospitals, Laboratory), Product & Service (Reagent, Software) - Forecast to 2021

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Molecular Diagnostics Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Molecular Diagnostics Market, By Region
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.2.1 Key Industry Insights
2.2.3 Assumptions

3 Executive Summary
3.1 Introduction
3.2 Conclusion

4 Premium Insights
4.1 Molecular Diagnostics: Market Overview
4.2 Molecular Diagnostics Market Size, By Type of Infectious Disease, 2016 vs 2021
4.3 Market, By Technology and Application
4.4 Market Size, By End User, 2016 vs 2021
4.5 Market Size, By Product and Service, 2016 vs 2021
4.6 Geographic Growth Opportunities

5 Molecular Diagnostics Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Prevalence of Infectious Diseases and Various Types of Cancer
5.2.1.2 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
5.2.1.3 Growth in the Biomarker Identification Market and Advancements in Molecular Techniques
5.2.1.4 Reforms in the Reimbursement System in the U.S.
5.2.2 Restraints
5.2.2.1 Complex Regulatory Frameworks to Delay Approvals of New Molecular Diagnostic Tests
5.2.3 Opportunities
5.2.3.1 Advances in Genomics and Proteomics
5.2.3.2 Increasing Adoption of Point-Of-Care Testing
5.2.3.3 Significant Growth Prospects in Developing Countries
5.2.4 Challenge
5.2.4.1 Dearth of Trained Professionals Limiting the Appropriate Use of New Molecular Diagnostic Technologies

6 Molecular Diagnostics Market, By Application
6.1 Introduction
6.2 Infectious Diseases
6.2.1 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
6.2.2 Hepatitis B
6.2.3 Human Papillomavirus (HPV)
6.2.4 Human Immunodeficiency Virus (HIV)
6.2.5 Tuberculosis (TB)
6.2.6 Hepatitis C
6.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
6.2.8 Other Infectious Diseases
6.3 Oncology
6.3.1 Breast Cancer
6.3.2 Colorectal Cancer
6.3.3 Prostate Cancer
6.3.4 Other Cancers
6.4 Blood Screening
6.5 Genetic Tests
6.6 Microbiology
6.7 Other Applications

7 Molecular Diagnostics Market, By Technology
7.1 Introduction
7.2 Polymerase Chain Reaction (PCR)
7.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.4 Hybridization (In-Situ Hybridization & Fish)
7.5 DNA Sequencing and Next-Generation Sequencing
7.6 Microarray
7.7 Other Technologies

8 Molecular Diagnostics Market, By Products and Services
8.1 Introduction
8.2 Reagents & Kits
8.3 Instruments
8.4 Software & Services

9 Molecular Diagnostics Market, By End User
9.1 Introduction
9.2 Hospital and Academic Laboratories
9.3 Reference Laboratories
9.4 Other End Users

10 Molecular Diagnostics Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 Italy
10.3.4 Spain
10.3.5 U.K.
10.3.6 Rest of Europe (RoE)
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 Australia
10.4.4 India
10.4.5 Rest of Asia-Pacific (RoAPAC)
10.5 Rest of the World (RoW)
10.5.1 Latin America
10.5.1.1 Brazil
10.5.1.2 Mexico
10.5.1.3 Rest of Latin America (ROLA)
10.5.2 Middle East & Africa

11 Competitive Landscape
11.1 Overview
11.2 Molecular Diagnostics Market Share Analysis
11.3 Market Competitor Share Analysis, By Application
11.3.1 Market Share Analysis for Blood Screening Applications
11.3.2 Ranking for Microbiology Applications
11.4 Molecular Diagnostics Market Share Analysis, By Technology
11.4.1 Polymerase Chain Reaction (PCR)
11.4.2 DNA Sequencing and NGs
11.4.3 Microarray
11.4.4 Hybridization (In Situ and Fluorescence)
11.4.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
11.5 New Product Launches and Approvals
11.6 Agreements, Collaborations, Partnerships, Joint Ventures, and Contracts
11.7 Acquisitions
11.8 Other Strategies

12 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 Introduction
12.2 Abbott Laboratories
12.3 Qiagen N.V.
12.4 Roche Diagnostics
12.5 Hologic, Inc.
12.6 Grifols
12.7 Siemens Healthcare
12.8 Becton, Dickinson and Company
12.9 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
12.10 Biomérieux Sa
12.11 Cepheid Inc.

13 Appendix
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports
13.8 Author Details

List of Tables

Table 1 Molecular Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 2 Infectious Disease Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 3 North America: Infectious Disease Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 4 Europe: Infectious Disease Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 5 Asia-Pacific: Infectious Disease Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 6 RoW: Infectious Disease Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 7 Latin America: Infectious Disease Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 8 Infectious Disease Diagnostics Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 9 CT/NG Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 10 CT/NG Diagnostics Market Size, By Region, 2014–2021 (Million Assays)
Table 11 Hepatitis B Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 12 Hepatitis B Diagnostics Market Size, By Region, 2014–2021 (Million Assays)
Table 13 HPV Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 14 HPV Diagnostics Market Size, By Region, 2014–2021 (Million Assays)
Table 15 HIV Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 16 HIV Diagnostics Market Size, By Region, 2014–2021 (Million Assays)
Table 17 TB Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 18 TB Diagnostics Market Size, By Region, 2014–2021 (Million Assays)
Table 19 Hepatitis C Market Size, By Region, 2014–2021 (USD Million)
Table 20 Hepatitis C Market Size, By Region, 2014–2021 (Million Assays)
Table 21 MRSA Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 22 MRSA Diagnostics Market Size, By Region, 2014–2021 (Million Assays)
Table 23 Other Infectious Disease Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 24 Oncology Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 25 North America: Oncology Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 26 Europe: Oncology Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 27 Asia-Pacific: Oncology Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 28 RoW: Oncology Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 29 Latin America: Oncology Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 30 Oncology Diagnostics Market Size, By Type, 2014–2021 (USD Million)
Table 31 Breast Cancer Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 32 Colorectal Cancer Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 33 Prostate Cancer Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 34 Other Cancer Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 35 Blood Screening Market Size, By Region, 2014–2021 (USD Million)
Table 36 North America: Blood Screening Market Size, By Country, 2014–2021 (USD Million)
Table 37 Europe: Blood Screening Market Size, By Country, 2014–2021 (USD Million)
Table 38 Asia-Pacific: Blood Screening Market Size, By Country, 2014–2021 (USD Million)
Table 39 RoW: Blood Screening Market Size, By Region, 2014–2021 (USD Million)
Table 40 Latin America: Blood Screening Market Size, By Country, 2014–2021 (USD Million)
Table 41 Genetic Tests Market Size, By Region, 2014–2021 (USD Million)
Table 42 North America: Genetic Tests Market Size, By Country, 2014–2021 (USD Million)
Table 43 Europe: Genetic Tests Market Size, By Country, 2014–2021 (USD Million)
Table 44 Asia-Pacific: Genetic Tests Market Size, By Country, 2014–2021 (USD Million)
Table 45 RoW: Genetic Tests Market Size, By Region, 2014–2021 (USD Million)
Table 46 Latin America: Genetic Tests Market Size, By Country, 2014–2021 (USD Million)
Table 47 Microbiology Market Size, By Region, 2014–2021 (USD Million)
Table 48 North America: Microbiology Market Size, By Country, 2014–2021 (USD Million)
Table 49 Europe: Microbiology Market Size, By Country, 2014–2021 (USD Million)
Table 50 Asia-Pacific: Microbiology Market Size, By Country, 2014–2021 (USD Million)
Table 51 RoW: Microbiology Market Size, By Region, 2014–2021 (USD Million)
Table 52 Latin America: Microbiology Market Size, By Country, 2014–2021 (USD Million)
Table 53 Other Molecular Diagnostic Applications Market Size, By Region, 2014–2021 (USD Million)
Table 54 North America: Other Molecular Diagnostic Applications Market Size, By Country, 2014–2021 (USD Million)
Table 55 Europe: Other Molecular Diagnostic Applications Market Size, By Country, 2014–2021 (USD Million)
Table 56 Asia-Pacific: Other Molecular Diagnostic Applications Market Size, By Country, 2014–2021 (USD Million)
Table 57 RoW: Other Molecular Diagnostic Applications Market Size, By Region, 2014–2021 (USD Million)
Table 58 Latin America: Other Molecular Diagnostic Applications Market Size, By Country, 2014–2021 (USD Million)
Table 59 Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 60 Market Size for PCR, By Region, 2014–2021 (USD Million)
Table 61 North America: Molecular Diagnostics Market Size for PCR, By Country, 2014–2021 (USD Million)
Table 62 Europe: Market Size for PCR, By Country, 2014–2021 (USD Million)
Table 63 Asia-Pacific: Molecular Diagnostics Market Size for PCR, By Country, 2014–2021 (USD Million)
Table 64 RoW: Market Size for PCR, By Region, 2014–2021 (USD Million)
Table 65 Latin America: Molecular Diagnostics Market Size for PCR, By Country, 2014–2021 (USD Million)
Table 66 Market Size for INAAT, By Region, 2014–2021 (USD Million)
Table 67 North America: Molecular Diagnostics Market Size for INAAT, By Country, 2014–2021 (USD Million)
Table 68 Europe: Market Size for INAAT, By Country, 2014–2021 (USD Million)
Table 69 Asia-Pacific: Molecular Diagnostics Market Size for INAAT, By Country, 2014–2021 (USD Million)
Table 70 RoW: Market Size for INAAT, By Region, 2014–2021 (USD Million)
Table 71 Latin America: Molecular Diagnostics Market Size for INAAT, By Country, 2014–2021 (USD Million)
Table 72 Market Size for Hybridization, By Region, 2014–2021 (USD Million)
Table 73 North America: Molecular Diagnostics Market Size for Hybridization, By Country, 2014–2021 (USD Million)
Table 74 Europe: Market Size for Hybridization, By Country, 2014–2021 (USD Million)
Table 75 Asia-Pacific: Molecular Diagnostics Market Size for Hybridization, By Country, 2014–2021 (USD Million)
Table 76 RoW: Market Size for Hybridization, By Region, 2014–2021 (USD Million)
Table 77 Latin America: Molecular Diagnostics Market Size for Hybridization, By Country, 2014–2021 (USD Million)
Table 78 Market Size for DNA Sequencing and NGs, By Region, 2014–2021 (USD Million)
Table 79 North America: Market Size for DNA Sequencing and NGs, By Country, 2014–2021 (USD Million)
Table 80 Europe: Molecular Diagnostics Market Size for DNA Sequencing and NGs, By Country, 2014–2021 (USD Million)
Table 81 Asia-Pacific: Market Size for DNA Sequencing and NGs, By Country, 2014–2021 (USD Million)
Table 82 RoW: Molecular Diagnostics Market Size for DNA Sequencing and NGs, By Region, 2014–2021 (USD Million)
Table 83 Latin America: Market Size for DNA Sequencing and NGs, By Country, 2014–2021 (USD Million)
Table 84 Molecular Diagnostics Market Size for Microarrays, By Region, 2014–2021 (USD Million)
Table 85 North America: Market Size for Microarrays, By Country, 2014–2021 (USD Million)
Table 86 Europe: Market Size for Microarrays, By Country, 2014–2021 (USD Million)
Table 87 Asia-Pacific: Molecular Diagnostics Market Size for Microarrays, By Country, 2014–2021 (USD Million)
Table 88 RoW: Market Size for Microarrays, By Region, 2014–2021 (USD Million)
Table 89 Latin America: Molecular Diagnostics Market Size for Microarrays, By Country, 2014–2021 (USD Million)
Table 90 Market Size for Other Technologies, By Region, 2014–2021 (USD Million)
Table 91 North America: Market Size for Other Technologies, By Country, 2014–2021 (USD Million)
Table 92 Europe: Molecular Diagnostics Market Size for Other Technologies, By Country, 2014–2021 (USD Million)
Table 93 Asia-Pacific: Market of Molecular Diagnostics: Size for Other Technologies, By Country, 2014–2021 (USD Million)
Table 94 RoW: Molecular Diagnostics Market Size for Other Technologies, By Region, 2014–2021 (USD Million)
Table 95 Latin America: Market Size for Other Technologies, By Country, 2014–2021 (USD Million)
Table 96 Molecular Diagnostics Market Size, By Products & Services, 2014–2021 (USD Million)
Table 97 Molecular Diagnostic Reagents & Kits Market Size, By Region, 2014–2021 (USD Million)
Table 98 North America: Molecular Diagnostic Reagents & Kits Market Size, By Country, 2014–2021 (USD Million)
Table 99 Europe: Molecular Diagnostic Reagents & Kits Market Size, By Country, 2014–2021 (USD Million)
Table 100 Asia-Pacific: Molecular Diagnostic Reagents & Kits Market Size, By Country, 2014–2021 (USD Million)
Table 101 RoW: Molecular Diagnostic Reagents & Kits Market Size, By Region, 2014–2021 (USD Million)
Table 102 Latin America: Molecular Diagnostic Reagents & Kits Market Size, By Country, 2014–2021 (USD Million)
Table 103 Molecular Diagnostic Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 104 North America: Molecular Diagnostic Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 105 Europe: Molecular Diagnostic Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 106 Asia-Pacific: Molecular Diagnostic Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 107 RoW: Molecular Diagnostic Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 108 Latin America: Molecular Diagnostic Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 109 Molecular Diagnostic Software & Services Market Size, By Region, 2014–2021 (USD Million)
Table 110 North America: Molecular Diagnostic Software & Services Market Size, By Country, 2014–2021 (USD Million)
Table 111 Europe: Molecular Diagnostic Software & Services Market Size, By Country, 2014–2021 (USD Million)
Table 112 Asia-Pacific: Molecular Diagnostic Software & Services Market Size, By Country, 2014–2021 (USD Million)
Table 113 RoW: Molecular Diagnostic Software & Services Market Size, By Region, 2014–2021 (USD Million)
Table 114 Latin America: Molecular Diagnostic Software & Services Market Size, By Country, 2014–2021 (USD Million)
Table 115 Molecular Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 116 Market Size for Hospital and Academic Laboratories, By Region, 2014–2021 (USD Million)
Table 117 North America: Market Size for Hospital and Academic Laboratories, By Country, 2014–2021 (USD Million)
Table 118 Europe: Molecular Diagnostics Market Size for Hospital and Academic Laboratories, By Country, 2014–2021 (USD Million)
Table 119 Asia-Pacific: Molecular Diagnostics Market Size for Hospital and Academic Laboratories, By Country, 2014–2021 (USD Million)
Table 120 RoW: Market Size for Hospital and Academic Laboratories, By Region, 2014–2021 (USD Million)
Table 121 Latin America: Molecular Diagnostics Market Size for Hospital and Academic Laboratories, By Country, 2014–2021 (USD Million)
Table 122 Molecular Diagnostics Market Size for Reference Laboratories, By Region, 2014–2021 (USD Million)
Table 123 North America: Market Size for Reference Laboratories, By Country, 2014–2021 (USD Million)
Table 124 Europe: Molecular Diagnostics Market Size for Reference Laboratories, By Country, 2014–2021 (USD Million)
Table 125 Asia-Pacific: Market Size for Reference Laboratories, By Country, 2014–2021 (USD Million)
Table 126 RoW: Molecular Diagnostics Market Size for Reference Laboratories, By Region, 2014–2021 (USD Million)
Table 127 Latin America: Market Size for Reference Laboratories, By Country, 2014–2021 (USD Million)
Table 128 Molecular Diagnostics Market Size for Other End Users, By Region, 2014–2021 (USD Million)
Table 129 North America: Molecular Diagnostics Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 130 Europe: Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 131 Asia-Pacific: Molecular Diagnostics Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 132 RoW: Market Size for Other End Users, By Region, 2014–2021 (USD Million)
Table 133 Latin America: Molecular Diagnostics Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 134 Market Size, By Region, 2014–2021 (USD Million)
Table 135 North America: Molecular Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 136 North America: Market Size, By Technology, 2014–2021 (USD Million)
Table 137 North America: Molecular Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 138 North America: Market Size, By Product and Service, 2014–2021 (USD Million)
Table 139 North America: Molecular Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 140 U.S.: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 141 U.S.: Market Size, By Application, 2014–2021 (USD Million)
Table 142 U.S.: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 143 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 144 Canada: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 145 Canada: Market Size, By Application, 2014–2021 (USD Million)
Table 146 Canada: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 147 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 148 Europe: Molecular Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 149 Europe: Market Size, By Technology, 2014–2021 (USD Million)
Table 150 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 151 Europe: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 152 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 153 Germany: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 154 Germany: Market Size, By Application, 2014–2021 (USD Million)
Table 155 Germany: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 156 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 157 France: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 158 France: Market Size, By Application, 2014–2021 (USD Million)
Table 159 France: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 160 France: Market Size, By End User, 2014–2021 (USD Million)
Table 161 Italy: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 162 Italy: Market Size, By Application, 2014–2021 (USD Million)
Table 163 Italy: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 164 Italy: Market Size, By End User, 2014–2021 (USD Million)
Table 165 Spain: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 166 Spain: Market Size, By Application, 2014–2021 (USD Million)
Table 167 Spain: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 168 Spain: Market Size, By End User, 2014–2021 (USD Million)
Table 169 U.K.: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 170 U.K.: Market Size, By Application, 2014–2021 (USD Million)
Table 171 U.K.: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 172 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 173 RoE: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 174 RoE: Market Size, By Application, 2014–2021 (USD Million)
Table 175 RoE: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 176 RoE: Market Size, By End User, 2014–2021 (USD Million)
Table 177 Asia-Pacific: Molecular Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 178 Asia-Pacific: Market Size, By Technology, 2014–2021 (USD Million)
Table 179 Asia-Pacific: Molecular Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 180 Asia-Pacific: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 181 Asia-Pacific: Market Size, By End User, 2014–2021 (USD Million)
Table 182 Japan: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 183 Japan: Market Size, By Application, 2014–2021 (USD Million)
Table 184 Japan: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 185 Japan: Market Size, By End User, 2014–2021 (USD Million)
Table 186 China: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 187 China: Market Size, By Application, 2014–2021 (USD Million)
Table 188 China: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 189 China: Market Size, By End User, 2014–2021 (USD Million)
Table 190 Australia: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 191 Australia: Market Size, By Application, 2014–2021 (USD Million)
Table 192 Australia: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 193 Australia: Market Size, By End User, 2014–2021 (USD Million)
Table 194 India: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 195 India: Market Size, By Application, 2014–2021 (USD Million)
Table 196 India: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 197 India: Market Size, By End User, 2014–2021 (USD Million)
Table 198 RoAPAC: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 199 RoAPAC: Market Size, By Application, 2014–2021 (USD Million)
Table 200 RoAPAC: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 201 RoAPAC: Market Size, By End User, 2014–2021 (USD Million)
Table 202 RoW: Molecular Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 203 RoW: Market Size, By Technology, 2014–2021 (USD Million)
Table 204 RoW: Market Size, By Application, 2014–2021 (USD Million)
Table 205 RoW: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 206 RoW: Market Size, By End User, 2014–2021 (USD Million)
Table 207 Latin America: Molecular Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 208 Latin America: Market Size, By Technology, 2014–2021 (USD Million)
Table 209 Latin America: Market Size, By Application, 2014–2021 (USD Million)
Table 210 Latin America: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 211 Latin America: Market Size, By End User, 2014–2021 (USD Million)
Table 212 Brazil: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 213 Brazil: Market Size, By Application, 2014–2021 (USD Million)
Table 214 Brazil: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 215 Brazil: Market Size, By End User, 2014–2021 (USD Million)
Table 216 Mexico: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 217 Mexico: Market Size, By Application, 2014–2021 (USD Million)
Table 218 Mexico: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 219 Mexico: Market Size, By End User, 2014–2021 (USD Million)
Table 220 RoLA: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 221 RoLA: Market Size, By Application, 2014–2021 (USD Million)
Table 222 RoLA: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 223 RoLA: Market Size, By End User, 2014–2021 (USD Million)
Table 224 Middle East & Africa: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 225 Middle East & Africa: MarketSize, By Application, 2014–2021 (USD Million)
Table 226 Middle East & Africa: Market Size, By Product and Service, 2014–2021 (USD Million)
Table 227 Middle East & Africa: Molecular Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 228 New Product Launches and Approvals, 2013–2016
Table 229 Agreements, Collaborations, Partnerships, Joint Ventures, and Contracts, 2013–2016
Table 230 Acquisitions, 2014–2016
Table 231 Other Strategies, 2013–2016

List of Figures

Figure 1 Research Design
Figure 2 Molecular Diagnostics Market: Top-Down Approach
Figure 3 Molecular Diagnostics Market: Bottom-Up Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Data Triangulation Methodology
Figure 6 Molecular Diagnostics Market Snapshot (2016 vs 2021)
Figure 7 Market Size, By Product & Service, 2016 vs 2021
Figure 8 Molecular Diagnostics Market Size, By End User, 2016 vs 2021
Figure 9 Molecular Diagnostics Market Size, By Application, 2016 vs 2021
Figure 10 Market Size, By Technology, 2016 vs 2021
Figure 11 Geographical Snapshot of the Molecular Diagnostics Market
Figure 12 Rising Prevalence of Infectious Diseases & Cancer to Drive Market Growth
Figure 13 MRSA to Be the Fastest-Growing Segment During the Forecast Period
Figure 14 Infectious Diseases Segment to Dominate the Market of Molecular Diagnostics in 2016
Figure 15 Hospitals & Academic Laboratories Will Continue to Dominate the Global Molecular Diagnostics Market in 2021
Figure 16 Reagents & Kits to Grow at the Highest Rate Between 2016 & 2021
Figure 17 Asia-Pacific to Register the Highest CAGR During the Forecast Period
Figure 18 Molecular Diagnostics Market: Drivers, Restraints, Opportunities, and Threats
Figure 19 Growth in the Number of People Living With HIV in 2010 and 2015 (Millions)
Figure 20 Infectious Diseases Segment to Dominate the Molecular Diagnostic Applications Market During the Forecast Period
Figure 21 PCR to Dominate the Molecular Diagnostic Technologies Market During the Forecast Period
Figure 22 Reagents & Kits to Form the Largest Segment of the Molecular Diagnostics Market in 2016
Figure 23 Hospital and Academic Laboratories—The Major End Users of Molecular Diagnostics
Figure 24 Asia-Pacific Will Be the Fastest-Growing Region in the Market
Figure 25 North America Molecular Diagnostics Market Snapshot
Figure 26 Germany, the Dominant Country in the European Molecular Diagnostics Market
Figure 27 Japan Will Continue to Lead the Asia-Pacific Market
Figure 28 Asia-Pacific: Molecular Diagnostics Market Snapshot
Figure 29 Latin America Will Continue to Lead the Asia-Pacific Molecular Diagnostics Market During the Forecast Period
Figure 30 Brazil to Command the Largest Share of the Latin American Molecular Diagnostics Market in 2021
Figure 31 Product Launches and Approvals: Key Strategies Adopted in the Last Three Years
Figure 32 Global Molecular Diagnostics Market Share, By Key Player, 2015
Figure 33 Global Blood Screening Market Share, By Key Player, 2015
Figure 34 Global Microbiology, Key Player Ranking, 2014
Figure 35 Global Market of Molecular Diagnostics: for PCR, Market Share Analysis, By Key Player, 2015
Figure 36 Global Molecular Diagnostics Market for DNA Sequencing and NGs, Market Share Analysis, By Key Player, 2015
Figure 37 Global Molecular Diagnostics Market for Microarray, Market Share Analysis, By Key Player, 2015
Figure 38 Global Market for Hybridization, Key Player Ranking, 2015
Figure 39 Global Market for INAAT, Key Player Ranking, 2015
Figure 40 Battle for Market Share: Product Launches and Approvals Was the Key Growth Strategy
Figure 41 Geographic Revenue Mix of the Top Five Market Players
Figure 42 Abbott Laboratories: Company Snapshot (2015)
Figure 43 Qiagen N.V.: Company Snapshot (2015)
Figure 44 Roche Diagnostics: Company Snapshot (2015)
Figure 45 Hologic, Inc.: Company Snapshot (2015)
Figure 46 Grifols: Company Snapshot (2015)
Figure 47 Siemens Healthcare: Company Snapshot (2016)
Figure 48 Becton, Dickinson and Company: Company Snapshot (2015)
Figure 49 Danaher Corporation: Company Snapshot (2015)
Figure 50 Biomérieux: Company Snapshot (2015)
Figure 51 Cepheid Inc.: Company Snapshot (2015)

  • Molecular Diagnostics Market (By Application, Technology, Region and Companies) and Forecast to 2021 - Global Analysis
    Published: 19-Sep-2016        Price: US 1100 Onwards        Pages: 149
    The molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. Molecular diagnostics is a new class of diagnostic tests that identify molecular and genetic markers for an individual patient. These markers determine potential benefit from a specific therapy or risk of developing a specific disease or other health condition. North America, particularly, United States is the key market for molecular diagnostics due to the availability of govern......
  • Molecular Diagnostics Market – Global Industry Analysis, Size, Share, Growth Trends & Forecast to 2021
    Published: 01-Jul-2016        Price: US 1000 Onwards        Pages: 117
    Molecular Diagnostics has emerged as one of the largest and fastest growing segment in the IVD industry. It is the most dynamic and transformative areas of diagnostics, leading to advances in research and treatment that are revolutionizing healthcare across a wide range of diseases and health conditions and has been driven by accuracy, high sensitivity, fast turnaround time, easy workflow, and cost–effective testing. The global molecular diagnostics market is projected to reach ......
  • Future Horizons and Growth Strategies in the Global Nucleic Acid Testing Market 2014: Supplier Shares and Country Forecasts
    Published: 28-Aug-2014        Price: US 32200 Onwards        Pages: 1050
    Highlights Business and technological trends in seven major markets Fiveand ten-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Profiles of market players and start-up firms developing innovative technologies and products Specific product and business opportunities for instrument and consumable suppliers. Rationale Th......
  • Future Horizons and Growth Strategies in the European Nucleic Acid Testing Market 2014: Supplier Shares and Country Forecasts
    Published: 28-Aug-2014        Price: US 19700 Onwards        Pages: 970
    This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market pl......
  • 2014 Deep Research Report on Global and China Molecular Diagnostics Equipment Industry
    Published: 23-Aug-2014        Price: US 2200 Onwards        Pages: 231
    This is a professional and depth research report on Global and China Molecular Diagnostics Equipment industry. The report firstly introduced Molecular Diagnostics Equipment basic information included Molecular Diagnostics Equipment definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Molecular Diagnostics Equipment industry policy an......
  • Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape
    Published: 22-Jul-2014        Price: US 8750 Onwards        Pages: 570
    This new seven-country study from Venture Planning Group contains 570 pages, 42 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Report Highlights Market shares of leading suppliers Business and technolo......
  • European Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape
    Published: 22-Jul-2014        Price: US 4850 Onwards        Pages: 495
    This new five-country study from Venture Planning Group contains 495 pages, 28 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Report Highlights Market shares of leading suppliers Business and technolog......
  • United States (USA)-Molecular Diagnostics Market, Test Volume Forecast & Companies
    Published: 05-May-2014        Price: US 1490 Onwards        Pages: 128
    Renub Research study titled “United States (USA)-Molecular Diagnostics Market, Test Volume Forecast & Companies” provides a comprehensive assessment of the fast–evolving, high–growth Global Molecular Diagnostics Market. This 128 page report with 87 Figures studies the United States Molecular Diagnostics from 4 view points: Market and Forecast Application Wise Market & Forecast Application Wise Test Volume & Forecast Company Wise Molecular ......
  • 2014 Analysis of Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Strategic Profiles of Leading Suppliers
    Published: 10-Apr-2014        Price: US 3850 Onwards        Pages: 280
    This 280-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products. The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&am......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs